Erasca, Inc. Shares Outstanding (Cover Page)
Erasca, Inc. (ERAS) had Shares Outstanding (Cover Page) of 349.76 million shares as of 2026-08-04, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-04: Entity Common Stock, Shares Outstanding 349.76M shares.
- 2026-05-05: Entity Common Stock, Shares Outstanding 310.98M shares.
- 2026-03-05: Entity Common Stock, Shares Outstanding 310.80M shares.
- 2025-11-05: Entity Common Stock, Shares Outstanding 283.71M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-04 | 349.76M shares 10-Q · filed 2026-08-11 |
| 2026-05-05 | 310.98M shares 10-Q · filed 2026-05-11 |
| 2026-03-05 | 310.80M shares 10-K · filed 2026-03-12 |
| 2025-11-05 | 283.71M shares 10-Q · filed 2025-11-12 |
| 2025-08-05 | 283.67M shares 10-Q · filed 2025-08-12 |
| 2025-05-06 | 283.29M shares 10-Q · filed 2025-05-13 |
| 2025-03-13 | 283.27M shares 10-K · filed 2025-03-20 |
| 2024-11-05 | 282.73M shares 10-Q · filed 2024-11-12 |
| 2024-08-05 | 282.50M shares 10-Q · filed 2024-08-12 |
| 2024-05-02 | 173.36M shares 10-Q · filed 2024-05-08 |
| 2024-03-21 | 151.49M shares 10-K · filed 2024-03-27 |
| 2023-11-02 | 151.09M shares 10-Q · filed 2023-11-09 |
| 2023-08-03 | 151.04M shares 10-Q · filed 2023-08-10 |
| 2023-05-08 | 150.76M shares 10-Q · filed 2023-05-15 |
| 2023-03-16 | 150.59M shares 10-K · filed 2023-03-23 |
| 2022-11-02 | 122.36M shares 10-Q · filed 2022-11-09 |
| 2022-08-04 | 122.15M shares 10-Q · filed 2022-08-11 |
| 2022-05-05 | 121.86M shares 10-Q · filed 2022-05-12 |
| 2022-03-17 | 121.59M shares 10-K · filed 2022-03-24 |
| 2021-11-04 | 121.25M shares 10-Q · filed 2021-11-10 |
| 2021-08-15 | 121.22M shares 10-Q · filed 2021-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |